Oncolytics Biotech Stock Revenue
| ONC Stock | CAD 1.47 0.02 1.34% |
Oncolytics Biotech fundamentals help investors to digest information that contributes to Oncolytics Biotech's financial success or failures. It also enables traders to predict the movement of Oncolytics Stock. The fundamental analysis module provides a way to measure Oncolytics Biotech's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Oncolytics Biotech stock.
| Last Reported | Projected for Next Year | ||
| Total Revenue | 0.00 | 0.00 |
Oncolytics | Revenue |
Oncolytics Biotech Company Revenue Analysis
Oncolytics Biotech's Revenue is income that a firm generates from business activities such us rendering services or selling goods to customers. It is a crucial part of a business and an essential item when evaluating a company's financial statements. Revenues from a firm's primary business operations can be reported on the income statement as sales revenue, net sales, or simply sales, depending on the industry in which a given company operates.
Historical and Projected quarterly revenue of Oncolytics
Projected quarterly revenue analysis of Oncolytics Biotech provides investors and stakeholders with an insight into the company's performance and growth prospects. When actual revenues of Oncolytics Biotech match or exceed analyst estimates, it positively influences investor confidence and market perception, often leading to a rise in Oncolytics Biotech's stock price.
Oncolytics Revenue Driver Correlations
Understanding the fundamental principles of building solid financial models for Oncolytics Biotech is extremely important. It helps to project a fair market value of Oncolytics Stock properly, considering its historical fundamentals such as Revenue. Since Oncolytics Biotech's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Oncolytics Biotech's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Oncolytics Biotech's interrelated accounts and indicators.
Click cells to compare fundamentals
Revenue is typically recorded when cash or cash equivalents are exchanged for services or goods and can include products or services discounts, promotions, as well as early payments on invoices or services rendered in advance.
| Competition |
Oncolytics Current Deferred Revenue
Current Deferred Revenue |
|
Based on the latest financial disclosure, Oncolytics Biotech reported 0.0 of revenue. This is 100.0% lower than that of the Biotechnology sector and 100.0% lower than that of the Health Care industry. The revenue for all Canada stocks is 100.0% higher than that of the company.
Oncolytics Biotech is currently under evaluation in revenue category among related companies. Market size based on revenue of Health Care industry is now estimated at about 163.53 Million. Oncolytics Biotech adds roughly 0.0 in revenue claiming only tiny portion of equities under Health Care industry.Oncolytics Biotech Current Valuation Drivers
We derive many important indicators used in calculating different scores of Oncolytics Biotech from analyzing Oncolytics Biotech's financial statements. These drivers represent accounts that assess Oncolytics Biotech's ability to generate profits relative to its revenue, operating costs, and shareholders' equity. Below are some of Oncolytics Biotech's important valuation drivers and their relationship over time.
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Market Cap | 136.1M | 121.8M | 93.6M | 128.8M | 121.0M | 132.4M | |
| Enterprise Value | 122.5M | 91.0M | 53.0M | 117.5M | 89.9M | 113.3M |
Oncolytics Fundamentals
| Return On Equity | -1.03 | ||||
| Return On Asset | -0.55 | ||||
| Current Valuation | 77.89 M | ||||
| Shares Outstanding | 75.42 M | ||||
| Shares Owned By Insiders | 3.90 % | ||||
| Shares Owned By Institutions | 6.77 % | ||||
| Number Of Shares Shorted | 305.71 K | ||||
| Price To Earning | (4.18) X | ||||
| Price To Book | 4.21 X | ||||
| EBITDA | (33.71 M) | ||||
| Net Income | (27.75 M) | ||||
| Cash And Equivalents | 11.67 M | ||||
| Cash Per Share | 0.72 X | ||||
| Total Debt | 373 K | ||||
| Debt To Equity | 0.01 % | ||||
| Current Ratio | 8.81 X | ||||
| Book Value Per Share | 0.37 X | ||||
| Cash Flow From Operations | (28.45 M) | ||||
| Short Ratio | 3.38 X | ||||
| Earnings Per Share | (0.41) X | ||||
| Target Price | 6.67 | ||||
| Beta | 1.46 | ||||
| Market Capitalization | 110.87 M | ||||
| Total Asset | 38.82 M | ||||
| Retained Earnings | (446 M) | ||||
| Working Capital | 33.94 M | ||||
| Current Asset | 26.92 M | ||||
| Current Liabilities | 2.71 M | ||||
| Net Asset | 38.82 M |
About Oncolytics Biotech Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Oncolytics Biotech's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Oncolytics Biotech using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Oncolytics Biotech based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Oncolytics Biotech. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors. To learn how to invest in Oncolytics Stock, please use our How to Invest in Oncolytics Biotech guide.Note that the Oncolytics Biotech information on this page should be used as a complementary analysis to other Oncolytics Biotech's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Technical Analysis module to check basic technical indicators and analysis based on most latest market data.
Complementary Tools for Oncolytics Stock analysis
When running Oncolytics Biotech's price analysis, check to measure Oncolytics Biotech's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Oncolytics Biotech is operating at the current time. Most of Oncolytics Biotech's value examination focuses on studying past and present price action to predict the probability of Oncolytics Biotech's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Oncolytics Biotech's price. Additionally, you may evaluate how the addition of Oncolytics Biotech to your portfolios can decrease your overall portfolio volatility.
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum |